Abstract
Dengue virus (DENV) is a mosquito-borne human pathogen that causes a serious public-health threat in tropical and subtropical regions of the world. Neither a vaccine to prevent nor an effective therapeutic agent to treat DENV infection is currently available. We established a stable cell line harboring a luciferase-reporting DENV subgenomic replicon to screen for inhibitors of DENV. A total of 14,400 small-molecule (MW < 500 Da) chemicals were evaluated for their ability to reduce luciferase reporter activity in cell lysates. One effective compound was identified from the screening. This compound was found to reduce virus production but did not block virus entry in virus-based assay. Mode-of-action analysis revealed that this inhibitor suppressed viral RNA replication but did not affect replicon translation. This compound potentially could be developed as an anti-DENV agent and might be useful for dissecting the molecular mechanism of DENV replication.
Similar content being viewed by others
References
Gubler DJ (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10:100–103
Lindenbach BD, Rice CM (2001) Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Strauss SE (eds) Fields virology, vol 1, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 991–1041
Gu B, Ouzunov S, Wang L, Mason P, Bourne N, Cuconati A, Block TM (2006) Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen. Antiviral Res 70:39–50
Ng CY, Gu F, Pong WY, Chen YL, Lim SP, Davison A, Vasudenvan SG (2007) Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antiviral Res 76:222–231
Noueiry AO, Olivo PD, Slomczynska U, Zhou Y, Buscher B, Geiss B, Engle M, Roth RM, Chung KM, Samuel M, Diamond MS (2007) Identification of novel small-molecule inhibitors of West Nile virus infection. J Virol 81:11992–12004
Patkar CG, Larsen M, Owston M, Smith JL, Kuhn RJ (2009) Identification of inhibitors of yellow fever virus replication using a replicon-based high-throughput assay. Antimicrob Agent Chemother 53:4103–4114
Puig-Basagoiti F, Qing M, Dong H, Zhang B, Zou G, Yuan Z, Shi PY (2009) Identification and characterization of inhibitors of West Nile virus. Antiviral Res 83:71–79
Russell PK, Nisalak A (1967) Dengue virus neutralization by the plaque reduction neutralization test. J Immunol 99:291–294
Welsch S, Miller S, Romero-Brey I, Merz A, Bleck CK, Walther P, Fuller SD, Antony C, Krijnse-Locker J, Bartenschlager R (2009) Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 5:365–375
Diamond MS, Zachariah M, Harris E (2002) Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology 304:211–221
Zhang JH, Chung TDY, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation on high throughput screening assays. J Biomol Screen 4:67–73
Chen Y, Magurie T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM (1999) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature Med 3:866–871
Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, Smit JM, Wilschut J, Shi PY, Wenk MR, Schul W (2009) A small molecule fusion inhibitor of dengue virus. Antiviral Res 84:260–266
Wang QY, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, Phh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG (2009) A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother 53:1823–1831
Niyomrattanakit P, Chen YL, Dong H, Yin Z, Qing M, Glickman JF, Lin K, Mueller D, Voshol H, Lim JYH, Nilar S, Keller TH, Shi PY (2010) Inhibition of dengue virus polymerase by blocking of the RNA tunnel. J Virol 84:5678–5686
Acknowledgments
This work was supported by grants from Academia Sinica, Taiwan (AS-97-40-12), and National Health Research Institute, Taiwan (NHRI-EX99-9745SI). The authors thank Dr. Heiko Kuhn for manuscript editing.
Author information
Authors and Affiliations
Corresponding author
Additional information
Y.-C. Hsu and N.-C. Chen contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hsu, YC., Chen, NC., Chen, PC. et al. Identification of a small-molecule inhibitor of dengue virus using a replicon system. Arch Virol 157, 681–688 (2012). https://doi.org/10.1007/s00705-012-1224-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-012-1224-z